United States · FDA National Drug Code directory
BUPROPION HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-124_2c4ea3ff-7a39-c7f4-e063-6294a90a5746
- Product NDC
- 72189-124
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- BUPROPION HYDROCHLORIDE
- Labeler
- DIRECT RX
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200814
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-124-30) · 72189-124-30
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-124-72) · 72189-124-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →